- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
Supergen | Company Snapshot
-
![]()
-
-
-
Vol:
-
Last Trade:
|
SUPERGEN INC.
Supergen Inc. is an emerging pharmaceutical company dedicated to the acquisition, rapid development and commercialization of oncology therapies for solid tumors and hematological malignancies. The company seeks to minimize the time, expense and technical risk associated with drug commercialization by identifying and acquiring pharmaceutical compounds in the later stages of development, rather than committing significant resources to the research phase of drug discovery.
|
|
| Symbol: |
SUPG |
| Exchange(s): |
Nasdaq Stock Market |
| Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
| 5-Star Rating: |
 |
|
ANNUAL FINANCIALS
|
|
|
Dec 31, 2008
12 Months
us$
|
Dec 31, 2007
12 Months
us$
|
Dec 31, 2006
12 Months
us$
|
3Yr.
Growth
% Change
|
|
Total Revenue ($000):
|
38,420
|
22,950
|
38,080
|
8.40
|
|
Earnings before Interest & Tax ($000):
|
-9,150
|
13,490
|
-15,910
|
N/A
|
|
Profit/Loss ($000):
|
-9,110
|
13,080
|
-16,480
|
N/A
|
|
Earnings per Share:
|
-0.16
|
0.23
|
-0.31
|
N/A
|
|
Total Assets ($000):
|
97,760
|
100,440
|
88,040
|
10.09
|
|
Dividends Per Share
|
0.00
|
0.00
|
0.00
|
|
|
Return on Com. Equity:
|
-9.95
|
16.51
|
-25.34
|
|
|
Employees:
|
N/A
|
N/A
|
N/A
|
|
|
|
|
|
Trailing 12 Month Results
|
|
|
12 Months ended
Sep 30, 2009,us$
|
12 Months ended
Sep 30, 2008,us$
|
%Change
|
|
Total Revenue ($000):
|
41,220
|
34,280
|
20.25
|
|
Profit/Loss ($000):
|
-200
|
-1,380
|
85.51
|
|
Earnings per Share:
|
0.00
|
-0.02
|
100.00
|
|
Dividends Per Share
|
0.00
|
0.00
|
|
Number of Shares:
|
59,150,000
|
57,560,000
|
|
|
|
|
COMPANY INFORMATION
|
| Incorporation: |
United States |
| |
| Securities: |
SUPG-Q
|
|
| |
|
|
| |
|
|
Financial data is provided by Zacks Investment Research.
| |
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2009 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|
